HLA Class I Tissue Typing for Donor at Chughtai Lab

HLA Class I Tissue Typing for Donor at Chughtai Lab

Human Leukocyte Antigen (HLA) Class I Tissue Typing for Donor is a highly specialized molecular diagnostic test performed to assess the immunological compatibility between an organ or stem cell donor and a recipient. This test is a cornerstone of transplant medicine, designed to minimize the risk of graft rejection and graft-versus-host disease (GVHD). HLA Class I molecules, which include HLA-A, HLA-B, and HLA-C, are glycoproteins expressed on the surface of almost all nucleated cells in the human body. They play a critical role in the immune system by presenting intracellular peptides to CD8+ cytotoxic T lymphocytes, allowing the immune system to distinguish self from non-self. When a transplant is performed, the recipient's immune system may recognize the donor's HLA molecules as foreign, triggering a potent and potentially destructive immune response. Therefore, precise HLA typing of the donor is mandatory before any transplant procedure can take place.

At Chughtai Lab, Pakistan's premier diagnostic network headquartered in Lahore, HLA Class I Tissue Typing is performed using state-of-the-art molecular biology techniques. The laboratory utilizes advanced Polymerase Chain Reaction (PCR) methodologies, such as Sequence-Specific Oligonucleotide (SSO) probing and Sequence-Specific Priming (SSP), as well as Next-Generation Sequencing (NGS) for high-resolution allele typing. These advanced technologies ensure the highest level of accuracy, which is vital for clinical decision-making in bone marrow, stem cell, and solid organ transplantations. By identifying the specific alleles at the HLA-A, HLA-B, and HLA-C loci, transplant teams can calculate the degree of mismatch and predict the immunological success of the transplant. This test is of paramount clinical importance, providing the quantitative and qualitative genetic data necessary to facilitate safe, life-saving transplant procedures across Pakistan.

Clinical Procedure: What to Expect

Patient Preparation

Proper preparation is essential to ensure sample integrity and accurate molecular analysis. Donors undergoing HLA Class I Tissue Typing at Chughtai Lab should observe the following guidelines:

• No Fasting Required: Fasting is not necessary for this test. Donors can eat and drink normally before the sample collection.
• Medication Disclosure: Inform the healthcare provider and lab staff of all current medications, especially immunosuppressants, chemotherapy agents, or recent experimental therapies.
• Blood Transfusion History: It is critical to disclose any recent blood transfusions (within the last 3 months). Recent transfusions can temporarily introduce foreign white blood cells into the donor's circulation, potentially interfering with molecular typing results.
• Documentation: Bring official identification (such as CNIC) and the transplant physician's referral letter, as donor-recipient pairing documentation must be meticulously maintained.
• Hydration: Drink plenty of water before the test to facilitate easier venous access for blood collection.

During the Procedure

The collection of the sample for HLA Class I Tissue Typing is a straightforward and safe procedure. The process is conducted as follows:

• Patient Identification and Verification: The phlebotomist will verify the donor's identity using at least two independent identifiers to ensure absolute accuracy in labeling.
• Positioning: The donor will be seated comfortably in a blood collection chair.
• Vein Selection and Sanitization: The phlebotomist will locate a suitable vein, typically in the antecubital fossa (inner elbow), and cleanse the area thoroughly with an antiseptic solution (70% isopropyl alcohol) to prevent contamination.
• Venipuncture: A sterile, single-use needle will be inserted into the vein to draw blood. For molecular HLA typing, blood is collected in an acid citrate dextrose (ACD) tube or an ethylenediaminetetraacetic acid (EDTA) tube, which preserves the genomic DNA.
• Duration: The actual blood draw takes less than five minutes.
• Post-Collection Care: Gentle pressure will be applied to the puncture site with a sterile cotton ball, followed by the application of a bandage. The donor can resume normal activities immediately.
• Safety and Quality Control: Chughtai Lab adheres to strict biosafety protocols. All equipment used is sterile and disposable, eliminating any risk of cross-contamination or infection.

When is a HLA Class I Tissue Typing for Donor Performed?

Hematopoietic Stem Cell Transplantation (HSCT)

HLA Class I Tissue Typing is critically required when evaluating a potential donor for bone marrow or peripheral blood stem cell transplantation. In cases of hematological malignancies such as leukemia, lymphoma, or severe aplastic anemia, finding a closely matched donor is essential. High-resolution HLA Class I typing helps identify whether a sibling, unrelated donor, or haploidentical family member shares the same HLA-A, HLA-B, and HLA-C alleles, which dramatically reduces the risk of life-threatening graft-versus-host disease (GVHD).

Solid Organ Transplantation

For patients requiring a kidney, liver, heart, or pancreas transplant, HLA Class I typing of the donor is performed to assess compatibility with the recipient. In solid organ transplantation, matching HLA antigens helps minimize the risk of acute and chronic graft rejection. While a perfect match is not always required for solid organs (unlike stem cell transplants), knowing the donor's HLA profile allows the transplant team to assess the immunological risk and tailor the recipient's post-transplant immunosuppressive therapy.

Preventing Graft-Versus-Host Disease (GVHD)

Graft-versus-host disease occurs when the immunocompetent T cells present in the donor's graft recognize the recipient's tissues as foreign and mount an immune attack against them. This is a major complication of allogeneic stem cell transplants. Performing detailed HLA Class I typing on the donor allows clinicians to select the donor with the lowest mismatch profile, directly mitigating the risk of severe, acute, or chronic GVHD in the recipient.

Pre-Transplant Crossmatching and Antibody Assessment

HLA Class I typing of the donor is performed in conjunction with recipient antibody screening (such as Panel Reactive Antibody or Single Antigen Bead assays). By knowing the donor's exact HLA Class I alleles, clinicians can determine if the recipient possesses pre-existing Donor-Specific Antibodies (DSAs). The presence of DSAs against donor HLA-A, HLA-B, or HLA-C antigens is a major contraindication to transplantation, as it can lead to hyperacute or accelerated acute humoral rejection.

Family Donor Screening

When a patient is identified as a transplant candidate, their immediate family members (siblings, parents, and children) are screened using HLA Class I typing. Because HLA genes are inherited co-dominantly as haplotypes (one set from each parent), siblings have a 25% chance of being a perfect 10/10 or 8/8 match. Typing family members is the first and most crucial step in identifying a compatible living donor for both renal and hematopoietic stem cell transplants.

What Does a HLA Class I Tissue Typing for Donor Detect?

HLA Class I Tissue Typing is designed to detect and identify the specific alleles present at the major Class I loci on Chromosome 6. The test evaluates several key molecular and genetic parameters:

• HLA-A Locus Alleles: Identifies the specific inherited alleles at the HLA-A locus (e.g., HLA-A*02, HLA-A*24), which encode the alpha chain of the HLA-A molecule.
• HLA-B Locus Alleles: Detects the highly polymorphic alleles at the HLA-B locus (e.g., HLA-B*27, HLA-B*57), which is the most polymorphic locus in the human genome.
• HLA-C Locus Alleles: Determines the alleles at the HLA-C locus, which play a key role in interacting with Killer Cell Immunoglobulin-like Receptors (KIR) on Natural Killer (NK) cells.
• Low-Resolution (Antigen-Level) Typing: Identifies the broad antigen groups (e.g., HLA-A2, HLA-B7), which is typically sufficient for initial solid organ transplant screening.
• High-Resolution (Allele-Level) Typing: Determines the exact genomic sequence of the HLA genes at the level of specific amino acid differences (e.g., HLA-A*02:01). This level of resolution is mandatory for stem cell and bone marrow donor selection.
• Haplotype Sharing: Determines the specific combination of HLA-A, B, and C alleles inherited together on a single chromosome, helping map familial inheritance patterns.
• Homozygosity vs. Heterozygosity: Detects whether the donor carries identical alleles (homozygous) or different alleles (heterozygous) at each of the Class I loci.
• Null Alleles: Identifies rare genetic variants that do not express functional HLA proteins on the cell surface, which is critical for avoiding false-positive match assumptions.
• Mismatched Loci Count: Quantifies the exact number of differences between the donor's Class I antigens and those of the recipient, allowing for mismatch scoring (e.g., 1-antigen mismatch, 2-antigen mismatch).

Turnaround Time and Report Access at Chughtai Lab

Because HLA Class I Tissue Typing involves complex molecular biology techniques, including DNA extraction, PCR amplification, and high-resolution hybridization or sequencing, the turnaround time is longer than routine blood tests. At Chughtai Lab, the standard turnaround time for HLA Class I Tissue Typing is typically 5 to 7 working days. This timeframe ensures that the rigorous multi-step quality control protocols are met, and the results are verified by a consultant molecular pathologist.

Chughtai Lab offers highly convenient methods for patients and donors to access their diagnostic reports. Once the report is finalized and signed off by the consultant, an automated SMS notification is sent to the registered mobile number. Reports can be viewed, downloaded, and printed directly from the official Chughtai Lab website by entering the patient ID and case number. Additionally, patients can access their complete diagnostic history via the Chughtai Lab Mobile App, available on both iOS and Android platforms. For those who prefer physical copies, reports can be collected from any of Chughtai Lab's numerous collection centers across Lahore and other major cities in Pakistan, or delivered directly to their doorstep through the lab's home delivery service.

HLA Class I Tissue Typing Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal / Incompatible Findings
HLA-A Locus	Successful identification of two functional HLA-A alleles (heterozygous) or one allele (homozygous).	Presence of null alleles (non-expressed); high-resolution mismatch with the intended recipient.
HLA-B Locus	Successful identification of two functional HLA-B alleles; clear determination of polymorphism.	Detection of alleles associated with high immunogenicity or specific disease susceptibilities; recipient mismatch.
HLA-C Locus	Successful identification of two functional HLA-C alleles, compatible with recipient KIR profiles.	HLA-C mismatch, which may trigger NK cell-mediated graft rejection or GVHD in stem cell transplants.
Resolution Level	High-resolution (4-digit or higher) typing achieved for stem cell donors; low-resolution for solid organs.	Incomplete resolution due to low DNA yield or quality, requiring sample recollection.
Haplotype Match Score	Perfect match (6/6 for Class I HLA-A, B, C) between donor and recipient.	Partial match (e.g., 4/6 or 3/6) or complete mismatch, indicating high risk of rejection.
DNA Quality and Yield	High-purity genomic DNA extracted from the donor's peripheral blood sample.	Degraded DNA or low yield, often due to improper sample storage or recent blood transfusions.
Donor-Specific Antibody (DSA) Crossmatch	Negative crossmatch; recipient does not have pre-existing antibodies against donor HLA Class I antigens.	Positive crossmatch; recipient has pre-existing antibodies against donor HLA-A, B, or C, indicating high risk of hyperacute rejection.

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient's symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Chughtai Lab for HLA Class I Tissue Typing?

• Experienced Healthcare Professionals: Chughtai Lab employs highly qualified molecular pathologists, geneticists, and technologists specializing in histocompatibility and immunogenetics.
• Patient-Focused Care: The lab provides a compassionate, supportive environment for donors and patients throughout the transplant workup process.
• Quality Diagnostic Services: Chughtai Lab adheres to stringent international quality control standards, ensuring highly accurate and reproducible molecular results.
• Professional Reporting: Reports are detailed, structured, and easy for transplant physicians to interpret, containing precise allele designations.
• Modern Diagnostic Approach: The molecular diagnostics division is equipped with cutting-edge PCR and sequencing platforms to perform high-resolution HLA typing.
• Comfortable Environment: All collection centers are designed to provide a clean, hygienic, and comfortable experience for donors during sample collection.
• Convenient Location: With a vast network of collection centers across Lahore and nationwide, donors can easily find a facility close to home.
• Commitment to Accurate Diagnosis: Chughtai Lab is dedicated to providing reliable, timely, and clinically actionable data to support successful transplant outcomes in Pakistan.